Successful management of tachycardiac atrial fibrillation in a septic patient with landiolol [8]

Anesthesia and Analgesia

Volumn 100, Issue 1, 2005, Pages 294-

  Yoshida, Yuko ^a   Hongo, Takashi ^a   Sakamoto, Atsuhiro ^a   Ogawa, Ryo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; FENTANYL; LANDIOLOL; NICORANDIL; PHENYLEPHRINE; PROPRANOLOL; SEVOFLURANE;

AGED; ANESTHESIA INDUCTION; CASE REPORT; CLINICAL FEATURE; DRUG INFUSION; GENERAL ANESTHESIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RATE; HEART STROKE VOLUME; HUMAN; HYPOTENSION; LAPAROTOMY; LETTER; LUNG ARTERY PRESSURE; MALE; PERITONITIS; PRIORITY JOURNAL; SEPSIS; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HEMODYNAMIC PROCESSES; HUMANS; INTRAOPERATIVE COMPLICATIONS; LAPAROSCOPY; MALE; MORPHOLINES; PERITONITIS; SEPSIS; TACHYCARDIA; UREA;

EID: 10944263739     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000140814.28118.6F     Document Type: Letter

References (2)

1. Atarashi H, Kuruma A, Yashima M, et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther 2000;68:143-50.
2. Sasao J, Tarver SD, Kindscher JD, et al. In rabbits, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth 2001;48:985-9.